Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

philippines-Cabaero: Death blow on use of Ivermect

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154011
(Total Views: 594)
Posted On: 01/20/2022 9:56:37 PM
Posted By: crazyjogger925
philippines-Cabaero: Death blow on use of Ivermectin


Nini Cabaero
30 August 2021·2 min read

Recent statements by governments and the maker of Ivermectin against the use of the drug in the treatment of coronavirus disease (Covid-19) patients should finally settle the matter.

The statements of Merck and the health departments of the Philippines and the United States, among others, are like the death blow being delivered on the use of ivermectin in the treatment of Covid-19 patients. This practice of giving ivermectin to persons with Covid-19 should stop.

Merck, the maker of Ivermectin, had said that, while company scientists continued to examine findings of all available and emerging studies of ivermectin for the treatment of Covid-19, it has been identified to date that there is no scientific basis for a potential therapeutic effect against Covid-19 from pre-clinical studies and no meaningful evidence for clinical efficacy in patients with Covid-19.

The Merck statement was released on February 4, 2021, but it has been resurrected following a statement of the United States Centers for Disease Control and Prevention (CDC) that noted a rise in ivermectin prescriptions and in severe illness associated with the use of the drug in the treatment of Covid-19. The CDC statement, dated August 26, said human exposures and adverse effects associated with ivermectin have increased in 2021 compared to the pre-pandemic baseline.

There is a version of ivermectin that is allowed for humans, for illnesses caused by parasitic worms and head lice, but the US Food and Drug Administration (FDA) does not endorse it for Covid-19 treatment. The World Health Organization had said any use of ivermectin for Covid-19 patients should be for clinical trials only, under doctors’ supervision.

Despite these warnings and reports of people overdosing on ivermectin, some still take it as prevention against Covid-19 or to treat their infection. An overdose on ivermectin can cause nausea, seizures, coma, and even death.

In the Philippines, some people are seeking ivermectin because they read, heard or believed it could protect them, and the drug is affordable. With no cure, no medicine to treat the Sars-CoV-2 that causes Covid-19, it is understandable that people would turn to alternative methods. Even the FDA acknowledges that, with the rising number of cases and deaths, it is not surprising that some consumers will look for unconventional treatments, not authorized by the FDA.

Now that the warnings have been made and the maker of Ivermectin has declared there was no proof of the medicine’s therapeutic effect on patients, the use of the drug to manage Covid-19 infections should stop.

Some doctors have said it would be difficult to treat patients who have taken ivermectin, while others warned they would not accept such patients.

These recent warnings should strike a death blow on the practice of using ivermectin for Covid-19.


(3)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us